全球臨床試驗用品市場規模、佔有率、成長分析，依階段（第一階段、第二階段）、應用（製藥和生物製藥以及合約研究組織 (CRO)）- 2024-2031 年產業預測

Global Clinical Trial Supplies Market Size, Share, Growth Analysis, By Phase(Phase I, Phase II), By Application(Pharmaceutical and Biopharmaceutical, and Contract Research Organizations (CROs)) - Industry Forecast 2024-2031

出版日期: 2024年04月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球臨床試驗用品市場規模為29億美元，預計將從2023年的30.9億美元成長到2031年的51.1億美元，預測期間（2024-2031年）複合年成長率為6.5%。

在全球化趨勢不斷增強、臨床試驗活動激增以及生物製劑和生物相似藥測試不斷升級的推動下，全球臨床試驗用品市場經歷了顯著成長。生技製藥公司採用供應鏈管理系統來降低與研發相關的高成本，同時提高營運效率。值得注意的是，臨床試驗用品佔研發總支出的很大一部分。此外，試驗中的生物製品和溫度敏感藥物的日益普及促使對臨床試驗設施的需求增加。目前，大約 38% 的藥物表現出溫度敏感性，其中 35% 的後期藥物被歸類為生物製劑。與傳統藥物相比，生物製劑的不良反應發生率較低，因此對生物製劑的需求不斷增加。已開發經濟體和發展中經濟體對生物相似藥的需求增加進一步推動了市場成長。由於成本較低且病患招募流程簡化，臨床試驗主要在發展中經濟體進行。亞太、拉丁美洲、中東歐、中東等地區為生物製藥公司提供了相當大的經濟優勢。新加坡和中國政府撥款促進生物醫學研究，而拉丁美洲則因語言障礙的減少而受益於簡化的患者招募。此外，發展中經濟體的多樣化疾病狀況有利於針對罕見疾病的臨床試驗。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Catalent, Inc. (US)
Thermo Fisher Scientific Inc. (US)
Sharp Packaging Services (US)
PAREXEL International Corporation (US)
CordenPharma (Austria)
Almac Group (UK)
PCI Pharma Services (US)
Eurofins Scientific (Luxembourg)
ICON plc (Ireland)
Biocair International Ltd (UK)
DHL (Germany)
Marken (US)
Myoderm (US)
Movianto (Belgium)
Ancillare LP (US)
Intertek Group plc (UK)
KLIFO A/S (Denmark)
N-SIDE (Belgium)
Sharp Clinical Services (US)
PRA Health Sciences, Inc. (US)

簡介目錄

Product Code: SQMIG35D2077

The global clinical trial supplies market size was valued at USD 2.9 billion in 2022 and is poised to grow from USD 3.09 billion in 2023 to USD 5.11 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The global market for clinical trial supplies has experienced remarkable growth, fueled by the increasing trend of globalization, a surge in clinical trial activities, and the escalating testing of biologics and biosimilar drugs. Biopharmaceutical companies have adopted supply chain management systems to mitigate the high costs associated with research and development while enhancing operational efficiency. Notably, clinical trial supplies constitute a significant portion of the total R&D expenditure. Furthermore, the growing prevalence of biologics and temperature-sensitive drugs under trial has led to an uptick in demand for clinical trial facilities. Presently, approximately 38% of pharmaceutical drugs exhibit temperature sensitivity, with 35% of late-phase pharmaceutical drugs being categorized as biologics. The rising demand for biologics stems from their lower incidence of adverse effects compared to traditional drugs. Market growth is further propelled by the heightened demand for biosimilars across developed and developing economies. Clinical trials predominantly take place in developing economies due to lower costs and simplified patient recruitment processes. Regions such as Asia Pacific, Latin America, Central & Eastern Europe, and the Middle East offer considerable economic advantages to biopharmaceutical companies. Governments in Singapore and China allocate funds to foster biomedical research, while Latin America benefits from simplified patient recruitment owing to reduced language barriers. Moreover, the diverse disease landscape in developing economies facilitates clinical trials focusing on rare diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the global clinical trial supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Supplies Market Segmental Analysis

The global clinical trial supplies market is segmented based on phase, application, and region. By phase, the market is segmented into phase I, phase II, phase III, and phase IV. By application, the market is segmented into pharmaceutical and biopharmaceutical, and contract research organizations (CROs). By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Clinical Trial Supplies Market

An essential catalyst for the global clinical trial supplies market is the rising need for specialized drug products, particularly biologics. These intricate therapeutic agents demand specific clinical trial supplies to uphold their safety, effectiveness, and stability throughout the trial process. Biologics, distinguished by their complex molecular structure derived from living organisms, serve as vital treatments for a spectrum of ailments. Given their unique characteristics, biologics necessitate specialized clinical trial provisions, including precise refrigeration, tailored packaging materials, and sophisticated temperature monitoring systems. The escalating demand for biologics, fueled by their proven efficacy and reduced adverse effects compared to conventional therapies, is propelling the requirement for specialized clinical trial supplies.

Restraints in the Global Clinical Trial Supplies Market

A significant obstacle facing the global clinical trial supplies market is the exorbitant cost associated with conducting clinical trials. The expenses incurred in conducting these trials have witnessed a substantial increase in recent times, posing a restraint on market expansion. Furthermore, challenges abound in patient recruitment due to the intricacies involved, alongside stringent regulatory requirements that must be adhered to throughout the trial process. These complexities not only impede the growth of the market but also pose barriers for small and mid-sized companies seeking entry, thereby constraining the overall progression of the clinical trial supplies market.

Market Trends of the Global Clinical Trial Supplies Market

An emerging trend in the global clinical trial supplies market is the integration of blockchain technology. This technology presents a decentralized and transparent system capable of tracking and managing the clinical trial supply chain effectively, from production to patient delivery. By enabling real-time tracking of supplies, blockchain technology enhances operational efficiency, minimizes errors, and strengthens data security. As such, its adoption within the clinical trial supplies market is anticipated to rise significantly in the foreseeable future.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Clinical Trial Supplies Market by Phase

Market Overview
Phase I
Phase II
Phase III
and Phase IV

Global Clinical Trial Supplies Market by Application

Market Overview
Pharmaceutical and Biopharmaceutical
and Contract Research Organizations (CROs)

Global Clinical Trial Supplies Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Catalent, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Packaging Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PAREXEL International Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CordenPharma (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PCI Pharma Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocair International Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DHL (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Marken (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myoderm (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Movianto (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ancillare LP (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KLIFO A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
N-SIDE (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Clinical Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PRA Health Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments